Clinical Trials Directory

Trials / Completed

CompletedNCT00562627

Efficacy of Multimodal Peri- and Intraarticular Drug Injections in Total Knee Arthroplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Asker & Baerum Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Total knee arthroplasty (TKA) is associated with moderate to severe postoperative pain, causing patient discomfort, mobilisation and hospital discharge. The aim of this study is to: 1. Compare analgetic efficacy of to types of local infiltration analgesia in total knee arthroplasty. 2. Compare analgetic efficacy of local infiltration analgesia with continuous epidural analgesia.

Detailed description

Total knee arthroplasty (TKA) is increasingly common in the treatment of knee osteoarthritis. TKA is associated with moderate to severe postoperative pain, causing patient discomfort, mobilisation and hospital discharge. Continuous epidural analgesia is often used for controlling pain after TKA. Recent studies describe a new method for pain control after total knee arthroplasty which consists of local infiltration with local anesthetics and adrenaline. This infiltrations can be combined with ketorolac and/or morphine. The aim of this study is to: 1. Compare analgetic efficacy of to types of local infiltration analgesia in total knee arthroplasty. 2. Compare analgetic efficacy of local infiltration analgesia with continuous epidural analgesia.

Conditions

Interventions

TypeNameDescription
DRUGropivacaineintraoperative and 1. postoperative day
DRUGadrenalineintraoperative LIA (IV and IA) and continuous EDA
DRUGketorolacintraoperative and 1. postoperative day
DRUGmorphineintraoperative
DRUGfentanylcontinuous postoperatively
DRUGbupivacainecontinuous postoperatively

Timeline

Start date
2007-11-01
Primary completion
2009-06-01
Completion
2009-07-01
First posted
2007-11-22
Last updated
2011-08-08
Results posted
2011-08-08

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00562627. Inclusion in this directory is not an endorsement.